Piramal Pharma Limited (PPLPHARMA) — Financial Flexibility Index
Piramal Pharma Limited (PPLPHARMA) has a Financial Flexibility Index of 0.16x as of September 2025. Free cash flow of Rs13.23 Billion (operating CF Rs8.90 Billion minus capex Rs4.33 Billion) represents 0% of total liabilities (Rs81.16 Billion). Check Piramal Pharma Limited (PPLPHARMA) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Piramal Pharma Limited Financial Flexibility Index (2021–2026)
Historical Financial Flexibility Index trend for Piramal Pharma Limited across 6 annual periods. For the full cash flow conversion analysis, see PPLPHARMA operating cash flow.
Annual Financial Flexibility Index for Piramal Pharma Limited (2021–2026)
Year-by-year free cash flow to debt coverage for Piramal Pharma Limited. Explore PPLPHARMA operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (INR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2026 | 0.23x | Rs22.90 Billion | Rs14.00 Billion | Rs98.02 Billion | ▲ +13.3% |
| 2025 | 0.21x | Rs15.57 Billion | Rs8.92 Billion | Rs75.52 Billion | ▼ -11.1% |
| 2024 | 0.23x | Rs17.17 Billion | Rs10.05 Billion | Rs74.00 Billion | ▲ +24.1% |
| 2023 | 0.19x | Rs14.49 Billion | Rs4.84 Billion | Rs77.49 Billion | ▲ +150.3% |
| 2022 | 0.07x | Rs4.56 Billion | Rs2.55 Billion | Rs61.00 Billion | ▲ +33.3% |
| 2021 | 0.06x | Rs928.30 Million | Rs347.20 Million | Rs16.56 Billion | — |